Modeling cerebral blood flow and flow heterogeneity from magnetic resonance residue data.
about
Cerebral small vessel disease: Capillary pathways to stroke and cognitive declineThe role of capillary transit time heterogeneity in myocardial oxygenation and ischemic heart diseaseNonparametric Residue Analysis of Dynamic PET Data With Application to Cerebral FDG Studies in Normals.Reliable estimation of capillary transit time distributions using DSC-MRIThe 39 steps: evading error and deciphering the secrets for accurate dynamic susceptibility contrast MRI.VOXEL-LEVEL MAPPING OF TRACER KINETICS IN PET STUDIES: A STATISTICAL APPROACH EMPHASIZING TISSUE LIFE TABLESArterial spin labeling and dynamic susceptibility contrast CBF MRI in postischemic hyperperfusion, hypercapnia, and after mannitol injectionQuantitative cerebral blood flow in dynamic susceptibility contrast MRI using total cerebral flow from phase contrast magnetic resonance angiographyVessel size imaging reveals pathological changes of microvessel density and size in acute ischemia.Capillary dysfunction: its detection and causative role in dementias and strokeThe roles of cerebral blood flow, capillary transit time heterogeneity, and oxygen tension in brain oxygenation and metabolism.Analysis of dynamic contrast enhanced MRI.Laminar microvascular transit time distribution in the mouse somatosensory cortex revealed by Dynamic Contrast Optical Coherence Tomography.Blood pressure reduction does not reduce perihematoma oxygenation: a CT perfusion study.A generalized mathematical framework for estimating the residue function for arbitrary vascular networks.Functional and morphological effects of diazepam and midazolam on tumor vasculature in the 9L gliosarcoma brain tumor model using dynamic susceptibility contrast MRI: a comparative study.Effect of electrical forepaw stimulation on capillary transit-time heterogeneity (CTH).Diminished cerebral oxygen extraction and metabolic rate in sickle cell disease using T2 relaxation under spin tagging MRI.The potential of microvessel density in prediction of infarct growth: a two-month experimental study in vessel size imaging.Effects of tracer arrival time on flow estimates in MR perfusion-weighted imaging.The relationship between blood flow impairment and oxygen depletion in acute ischemic stroke imaged with magnetic resonance imaging.Tracer arrival timing-insensitive technique for estimating flow in MR perfusion-weighted imaging using singular value decomposition with a block-circulant deconvolution matrix.Dynamic hysteresis between gradient echo and spin echo attenuations in dynamic susceptibility contrast imaging.Modeling and correction of bolus dispersion effects in dynamic susceptibility contrast MRI.Simultaneous noninvasive measurement of CBF and CBV using double-echo FAIR (DEFAIR).Is quantification of bolus tracking MRI reliable without deconvolution?Tracer delay correction of cerebral blood flow with dynamic susceptibility contrast-enhanced MRI.Perfusion quantification using Gaussian process deconvolution.Mapping myocardial perfusion with an intravascular MR contrast agent: robustness of deconvolution methods at various blood flows.Quantification of myocardial blood flow and blood flow reserve in the presence of arterial dispersion: a simulation study.[Imaging-based indications for interventional treatment of stroke].Dexamethasone normalizes brain tumor hemodynamics as indicated by dynamic susceptibility contrast MRI perfusion parameters.Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhancedT1-weighted MRI
P2860
Q26776375-A0676C9B-BDED-44D3-9529-14BBF031C9ABQ26995434-3FC8212B-F98A-4029-BED0-76789E1985E4Q33510711-3C030AC8-0266-418F-9DF9-70D317EF42A8Q34153440-8FF57F4C-F165-411F-97BA-D9EF9231CDCBQ34332950-1A4A957D-D69F-4DDF-9F2A-E8BA7B50FD41Q34478768-222FF1A2-C756-47D4-919C-CF10B7763ADAQ35088178-48BD426A-134A-4356-A8C1-66041B993FCDQ35117036-FCACB340-72C8-4D6B-9091-C0DF43FDFC74Q35208012-CF9395B4-0EAE-45B9-9BB7-46A3FD9E35E1Q35639179-588DCC17-1908-4D4B-91EF-532C55F5FA1BQ35738328-B6AB8D96-4BC3-4AE7-B9CC-7AFFD2B668A5Q36022692-BC2EA8B8-5ABB-4917-B7D7-1AC330D87312Q36404889-43DA1E14-5673-44F6-8305-3DB9C42E546AQ37459861-C6242CD6-A823-4085-8E0F-9B6CF392EF15Q40186336-9DC39998-D9AD-4508-89D0-FE339A725D8DQ42373814-9BCB6E7A-E6D9-4649-A34C-CD53010F4380Q46138575-B623D1AB-0E05-4F39-809A-5CCC7B53AC62Q46453089-03E8CC25-0390-43DF-B94A-AF74CBD2D1B7Q47326026-FF3F6C18-464C-49A9-8718-7B5C180CC151Q47589380-99942519-1ABB-47B9-A986-58795E18D9E6Q47655626-CFAF593A-FD0F-435F-8B17-E7E047F6F2B8Q47818675-4993970D-E4AF-475E-B715-AAD25EE3D691Q48501713-8332EBDA-B55D-495D-9407-1E5E031A0D37Q48894200-D4164406-1224-4CFC-BBE5-78271FE9A61DQ48899730-43224A00-C656-40CC-BF99-012C48D11842Q49025904-4641C4DB-345B-4834-90E5-DB7D025D5B8FQ49108207-1228B160-057C-42A9-BEF0-287BE03AFCFBQ52033396-3B1D429D-AA1B-42F2-9160-AD5CAE6271DFQ52036943-F11D5727-7993-4099-86CF-D1E2270DA5EFQ52042881-49F2BC54-78E7-4418-9580-B1A71FE1F071Q52992057-3408C804-B156-480A-8B0D-A51FFC5B126BQ55471349-07914A86-A178-45C7-BAF1-7C682427E020Q56588929-316E955D-F3CB-4AAD-BF68-7F71F633FA46
P2860
Modeling cerebral blood flow and flow heterogeneity from magnetic resonance residue data.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Modeling cerebral blood flow and flow heterogeneity from magnetic resonance residue data.
@ast
Modeling cerebral blood flow and flow heterogeneity from magnetic resonance residue data.
@en
type
label
Modeling cerebral blood flow and flow heterogeneity from magnetic resonance residue data.
@ast
Modeling cerebral blood flow and flow heterogeneity from magnetic resonance residue data.
@en
prefLabel
Modeling cerebral blood flow and flow heterogeneity from magnetic resonance residue data.
@ast
Modeling cerebral blood flow and flow heterogeneity from magnetic resonance residue data.
@en
P2093
P2860
P1476
Modeling cerebral blood flow and flow heterogeneity from magnetic resonance residue data.
@en
P2093
Chesler DA
Ostergaard L
Sorensen AG
Weisskoff RM
P2860
P304
P356
10.1097/00004647-199906000-00013
P577
1999-06-01T00:00:00Z
P5875
P6179
1001023124